Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Fidelity Advisor Biotechnology Fund

+ Add to Watchlist

FBTTX:US

27.39 USD 0.67 2.51%

As of 09:29:30 ET on 03/05/2015.

Snapshot for Fidelity Advisor Biotechnology Fund (FBTTX)

Year To Date: +15.77% 3-Month: +16.65% 3-Year: +44.93% 52-Week Range: 16.58 - 27.39
1-Month: +10.62% 1-Year: +26.91% 5-Year: +33.02% Beta vs MXWO: 1.01

Mutual Fund Chart for FBTTX

No chart data available.
  • FBTTX:US 27.39
  • 1M
  • 1Y
Interactive FBTTX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FBTTX

Fidelity Advisor Biotechnology Fund is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes.

Inception Date: 12-27-2000 Telephone: 1-877-208-0098
Managers: RAJIV KAUL
Web Site: advisor.fidelity.com

Fundamentals for FBTTX

NAV (on 2015-03-05) 27.39
Assets (M) (on 2015-02-27) 2,835.18
Fund Leveraged N
Minimum Investment 2,500.00
Minimum Subsequent Investment 0.00

Dividends for FBTTX

Dividend Type Long Term Cap Gain
Dividend Frequency Semi-Anl
Last Dividend Net (on 2014-12-12) 0.42
Dividend Yield (ttm) 2.21

Fees & Expenses for FBTTX

Front Load 3.50
Back Load 0.00
Current Mgmt Fee 0.55
Redemption Fee 0.75
12b1 Fee 0.50
Expense Ratio 1.40

Top Fund Holdings for FBTTX

Filing Date: 01/31/2015
Name Position Value % of Total
Gilead Sciences Inc 2,767,007 290,065,344 1,161.202%
Celgene Corp 1,589,333 189,384,920 758.154%
Biogen Idec Inc 465,199 181,036,843 724.734%
Alexion Pharmaceuticals Inc 659,824 120,906,150 484.017%
Regeneron Pharmaceuticals Inc 252,661 105,273,732 421.436%
Vertex Pharmaceuticals Inc 916,326 100,924,146 404.024%
BioMarin Pharmaceutical Inc 705,538 68,550,072 274.423%
Amgen Inc 387,830 59,050,996 236.395%
Zafgen Inc 1,306,751 49,669,606 198.839%
Receptos Inc 450,142 49,592,144 198.529%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil